CN102058843A - Chinese medicine composition for treating fatty liver - Google Patents
Chinese medicine composition for treating fatty liver Download PDFInfo
- Publication number
- CN102058843A CN102058843A CN2010105751494A CN201010575149A CN102058843A CN 102058843 A CN102058843 A CN 102058843A CN 2010105751494 A CN2010105751494 A CN 2010105751494A CN 201010575149 A CN201010575149 A CN 201010575149A CN 102058843 A CN102058843 A CN 102058843A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- medicine composition
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 208000010706 fatty liver disease Diseases 0.000 title claims abstract description 28
- 208000004930 Fatty Liver Diseases 0.000 title claims abstract description 27
- 206010019708 Hepatic steatosis Diseases 0.000 title claims abstract description 27
- 231100000240 steatosis hepatitis Toxicity 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 241000628997 Flos Species 0.000 claims description 8
- 241001629511 Litchi Species 0.000 claims description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- 241001412627 Adenophora liliifolia Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 240000004307 Citrus medica Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 244000183278 Nephelium litchi Species 0.000 abstract 1
- 235000015742 Nephelium litchi Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 241000159213 Zygophyllaceae Species 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 13
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000000590 parasiticidal effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of traditional Chinese medicines. The invention aims at providing a Chinese medicine composition for treating fatty liver with good treatment effect and no side effects. The Chinese medicine composition is characterized by comprising the following Chinese medicinal herbs in parts by weight: 10-20 parts of the root of Chinese thorowax, 20-40 parts of white paeony root, 5-15 parts of fruit of immature citron, 5-15 parts of liquorice root, 10-20 parts of the fruit of Chinese wolfberry, 5-15 parts of szechwan Chinaberry fruit, 10-30 parts of rhizoma corydalis, 10-20 parts of pinellia ternate, 5-15 parts of baical skullcap root, 10-20 parts of tuber of aromatic turmeric, 20-40 parts of raw ossa draconis, 20-40 parts of raw concha ostreae, 10-20 parts of leechee, 5-15 parts of pericarpium citri reticulatae viride, 10-30 parts of the root of straight ladybell, 5-15 parts of chrysanthemum and 10-30 parts of caltrop.
Description
Technical field
The invention belongs to the Chinese medicine field, particularly a kind of Chinese medicine composition for the treatment of fatty liver.
Background technology
Fatty liver is meant because the pathological changes of the interior fatty overheap of the hepatocyte that a variety of causes causes.The positive serious threat compatriots' of fatty liver disease health becomes the second largest hepatopathy that is only second to viral hepatitis, has been acknowledged as the common cause of disguised liver cirrhosis.The Chinese traditional treatment fatty liver with depressed liver-energy dispersing and QI regulating, dissipating phlegm and removing blood stasis, soothing liver and strengthening spleen, damp eliminating reduce phlegm, nourishing the kidney and liver, blood circulation promoting and blood stasis dispelling, removing heat-phlegm, benefiting QI for activating blood circulation, dispersing swelling and dissipating binds etc. be principle.Because the Chinese traditional treatment fatty liver, good effect has no side effect, and welcome by the patient.
Summary of the invention
The purpose of this invention is to provide a kind of good effect, cost is low, the Chinese medicine composition of the treatment fatty liver that has no side effect.
The technical scheme that the present invention is taked for the above-mentioned technical problem of realization is, a kind of Chinese medicine composition for the treatment of fatty liver, it is characterized in that, form: Radix Bupleuri 10-20 part, Radix Paeoniae Alba 20-40 part by following materials of weight proportions medicine, Fructus Aurantii Immaturus 5-15 part, Radix Glycyrrhizae 5-15 part, Fructus Lycii 10-20 part, Fructus Toosendan 5-15 part, Rhizoma Corydalis 10-30 part, Rhizoma Pinelliae 10-20 part, Radix Scutellariae 5-15 part, Radix Curcumae 10-20 part, each 20-40 part of SHENGLONGMU, Fructus Litchi 10-20 part, Pericarpium Citri Reticulatae Viride 5-15 part, Radix Adenophorae (Radix Glehniae) 10-30 part, Flos Chrysanthemi 5-15 part, Fructus Tribuli 10-30 part.
The above-mentioned raw materials medicine is made medicament in the usual way, each 100ml, every day 1 time.
In the described material medicine:
Radix Bupleuri, hardship is slightly cold, and returns Liver Channel, gallbladder meridian.Evacuation is brought down a fever, the yang invigorating soothing liver-QI.Cold, fever, alternate attack of chill and fever, malaria, stagnation of QI due to depression of the liver, sternal rib pain, proctoptosis, the uterus comes off, menoxenia.
The Radix Paeoniae Alba, abnormal smells from the patient acid is flat.Bright all families of unit hand down and are the product of the cold convergence of acid, all interior deficiency diarrhea persons, use more to restrain.Cure mainly pathogen stomachache, and remove the arthralgia due to stagnation of blood cold and heat.
Fructus Aurantii Immaturus, hardship; Hot; Cold.Return spleen; Stomach; Liver; Heart channel.Stop in stagnant; The feeling of fullness distending pain; Constipation; Heavy behind the dysentery; Blocked-up chest; Gastroptosis; Uterine prolapse; Proctoptosis.
Radix Glycyrrhizae, property is flat, and sweet in the mouth is returned 12 warps.Detoxifcation arranged, eliminate the phlegm, pain relieving, spasmolytic be so that pharmacological action such as anticancer.On the traditional Chinese medical science, the Radix Glycyrrhizae invigorating the spleen and replenishing QI is grown and to be coughed lung moistening, and the emergency detoxifcation is in harmonious proportion hundred medicines.
Fructus Lycii, sweet in the mouth; Property is put down.Return Liver Channel; Kidney channel; Lung meridian.Nourishing the liver; Nourishing kidney; Lung moistening.Caused by liver and kidney deficiency; Have a dizzy spell; Visual one is clear; Soreness of the waist and knees; Impotence and seminal emission; Cough due to consumptive disease; The taking fluids profusely of quenching one's thirst.Fructus Toosendan, cold in nature, bitter in the mouth is a kind of of qi-activating drug.Mainly go into Liver Channel, the catharsis liver-heat, promoting the circulation of QI to relieve pain have except that damp and hot, clearing away liver-fire, pain relieving, parasiticidal function.
Rhizoma Corydalis, acrid in the mouth, hardship, warm in nature.Promoting blood circulation to remove blood stasis is arranged, promoting the circulation of QI analgesic function.Be used for pain of each qi depression to blood stasis of whole body, dysmenorrhea, amenorrhea, lump in the abdomen, postpartum stagnation, injury from falling down, hernia is had a pain.
The Rhizoma Pinelliae, suffering, temperature, poisonous.Go into spleen, stomach warp.The water of manageing it is wet, lowering the adverse flow of QI, and the kind taste damp-phlegm of dispelling.
Radix Scutellariae, hardship, cold.Return lung, gallbladder, spleen, large intestine, small intestine meridian.Heat clearing and damp drying, eliminating fire and detoxication, hemostasis, antiabortive, blood pressure lowering.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, the cough due to lung-heat, the hyperpyrexia excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, frequent fetal movement.
Radix Curcumae, hot, bitter, cold.Return liver, the heart, lung meridian.Regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice.Be used for the amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, the calentura coma, epilepsy is gone mad, the jaundice dark coloured urine.
Os Draconis, sweet puckery, flat, go into the heart, liver, kidney, large intestine channel, it is demented to be used for infantile convulsion, and palpitation with a distress feeling is forgetful, insomnia and dreamful sleep, spontaneous sweating, the seminal emission stranguria with turbid discharge is told nosebleed and is had blood in stool, bleeding not during menses, the dysentery proctoptosis, ulcer does not close up for a long time.
Concha Ostreae, salty wet, cool salty wet, liver, kidney channel are gone in cold.Be used for the palpitation with fear insomnia, vertigo and tinnitus, tuberculous lymphadenitis, abdominal mass mass in the abdomen, spontaneous sweating, seminal emission metrorrhagia and leukorrhagia, stomachache pantothenic acid.The Concha Ostreae (calcined) convergence is astringent or styptic treatment for spontaneous sweating.
Fructus Litchi, sweet acid, temperature.Go into spleen of Foot-Taiyin, liver channel of foot-Jueyin.Promote the production of body fluid, beneficial blood is regulated the flow of vital energy, pain relieving.Control excessive thirst, singultus, stomachache, scrofula, furuncle is swollen, toothache, traumatic hemorrhage.
Pericarpium Citri Reticulatae Viride, toil, temperature.Go into liver, gallbladder, stomach warp.Soothing the liver dispelling the stagnated QI, removing food stagnancyization stagnate.Be used for costa sternales gastral cavity distending pain, acute mastitis, colic, stagnation of QI due to dyspepsia.
Radix Adenophorae (Radix Glehniae), sweet, cold.Accumulation of blood is shied gas, removes cold and heat, invigorating middle warmer, lung benefiting gas.
Flos Chrysanthemi, acrid in the mouth, sweet, hardship; Cold nature.Return lung, Liver Channel.Diffusing wind heat clearing away, suppressing the hyperactive liver makes eye bright.Be used for anemopyretic cold, it is dizzy to have a headache, conjunctival congestion and swelling pain, and eyes is dim-sighted.
Fructus Tribuli, hot, bitter, tepor; Slightly poisonous.Return Liver Channel.The suppressing the hyperactive liver resolving depression, promoting blood circulation by removing wind makes eye bright, and is antipruritic.It is dizzy to be used to have a headache, distending pain in the chest and hypochondrium, and breast closes acute mastitis, conjunctival congestion cataracta, rubella pruritus.
The present invention will be further described below in conjunction with concrete case.
Case 1
The man, 54 years old, more fat inappetence, lassitude and weak, feel sick, lose weight, upper right abdomen dull pain.Through hospital diagnosis is fatty liver.
Take a kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, symptom significantly alleviates after 3 months.
Case 2
The man, 49 years old, lassitude and weak, the hepatic region has a dull ache.Through hospital diagnosis is fatty liver.
Take a kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, transference cure after 2 months.
Case 3
The man, 60 years old, fat, loss of appetite, lassitude and weak is felt sick, and loses weight.Through hospital diagnosis is fatty liver.
Take a kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, sx after 1 month.
Case 4
The man, 50 years old, more fat, long-term tired sense.Through hospital diagnosis is fatty liver.
Take a kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, recovery from illness after 1 month.
Case 5
The man, 57 years old, inappetence, lassitude and weak, lose weight, dull pain in liver.Through hospital diagnosis is fatty liver.
Take a kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, recovery from illness after 2 months.
A kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, treatment patient 40 examples, effective percentage 97%, cure rate 90%.
A kind of Chinese medicine composition for the treatment of fatty liver provided by the invention, prescription is simple, and cost is low, and good effect has no side effect.
The specific embodiment
The present invention will be further described below in conjunction with specific embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 15 grams, the Radix Paeoniae Alba 30 grams, Fructus Aurantii Immaturus 10 grams, Radix Glycyrrhizae 10 grams, Fructus Lycii 115 grams, Fructus Toosendan 10 grams, Rhizoma Corydalis 20 grams, the Rhizoma Pinelliae 15 grams, Radix Scutellariae 10 grams, Radix Curcumae 15 grams, each 30 gram of SHENGLONGMU, Fructus Litchi 15 grams, Pericarpium Citri Reticulatae Viride 10 grams, Radix Adenophorae (Radix Glehniae) 20 grams, Flos Chrysanthemi 10 grams, Fructus Tribuli 20 grams.
Embodiment 2
A kind of Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 10 grams, the Radix Paeoniae Alba 40 grams, Fructus Aurantii Immaturus 5 grams, Radix Glycyrrhizae 15 grams, Fructus Lycii 10 grams, Fructus Toosendan 15 grams, Rhizoma Corydalis 10 grams, the Rhizoma Pinelliae 20 grams, Radix Scutellariae 5 grams, Radix Curcumae 20 grams, each 20 gram of SHENGLONGMU, Fructus Litchi 20 grams, Pericarpium Citri Reticulatae Viride 5 grams, Radix Adenophorae (Radix Glehniae) 30 grams, Flos Chrysanthemi 5 grams, Fructus Tribuli 30 grams.
Embodiment 3
A kind of Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 20 grams, the Radix Paeoniae Alba 20 grams, Fructus Aurantii Immaturus 15 grams, Radix Glycyrrhizae 5 grams, Fructus Lycii 20 grams, Fructus Toosendan 5 grams, Rhizoma Corydalis 30 grams, the Rhizoma Pinelliae 10 grams, Radix Scutellariae 15 grams, Radix Curcumae 10 grams, each 40 gram of SHENGLONGMU, Fructus Litchi 10 grams, Pericarpium Citri Reticulatae Viride 15 grams, Radix Adenophorae (Radix Glehniae) 10 grams, Flos Chrysanthemi 15 grams, Fructus Tribuli 10 grams.
Embodiment 4
A kind of Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 12 grams, the Radix Paeoniae Alba 35 grams, Fructus Aurantii Immaturus 6 grams, Radix Glycyrrhizae 13 grams, Fructus Lycii 12 grams, Fructus Toosendan 13 grams, Rhizoma Corydalis 15 grams, the Rhizoma Pinelliae 18 grams, Radix Scutellariae 6 grams, Radix Curcumae 18 grams, each 25 gram of SHENGLONGMU, Fructus Litchi 18 grams, Pericarpium Citri Reticulatae Viride 7 grams, Radix Adenophorae (Radix Glehniae) 25 grams, Flos Chrysanthemi 6 grams, Fructus Tribuli 25 grams.
Embodiment 5
A kind of Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 18 grams, the Radix Paeoniae Alba 25 grams, Fructus Aurantii Immaturus 14 grams, Radix Glycyrrhizae 7 grams, Fructus Lycii 18 grams, Fructus Toosendan 7 grams, Rhizoma Corydalis 25 grams, the Rhizoma Pinelliae 12 grams, Radix Scutellariae 13 grams, Radix Curcumae 12 grams, each 35 gram of SHENGLONGMU, Fructus Litchi 13 grams, Pericarpium Citri Reticulatae Viride 13 grams, Radix Adenophorae (Radix Glehniae) 15 grams, Flos Chrysanthemi 14 grams, Fructus Tribuli 15 grams.
Claims (1)
1. a Chinese medicine composition for the treatment of fatty liver is characterized in that, is made up of following materials of weight proportions medicine: Radix Bupleuri 10-20 part, Radix Paeoniae Alba 20-40 part, Fructus Aurantii Immaturus 5-15 part, Radix Glycyrrhizae 5-15 part, Fructus Lycii 10-20 part, Fructus Toosendan 5-15 part, Rhizoma Corydalis 10-30 part, Rhizoma Pinelliae 10-20 part, Radix Scutellariae 5-15 part, Radix Curcumae 10-20 part, each 20-40 part of SHENGLONGMU, Fructus Litchi 10-20 part, Pericarpium Citri Reticulatae Viride 5-15 part, Radix Adenophorae (Radix Glehniae) 10-30 part, Flos Chrysanthemi 5-15 part, Fructus Tribuli 10-30 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105751494A CN102058843B (en) | 2010-11-24 | 2010-11-24 | Chinese medicine composition for treating fatty liver |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105751494A CN102058843B (en) | 2010-11-24 | 2010-11-24 | Chinese medicine composition for treating fatty liver |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102058843A true CN102058843A (en) | 2011-05-18 |
| CN102058843B CN102058843B (en) | 2012-05-23 |
Family
ID=43994468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105751494A Expired - Fee Related CN102058843B (en) | 2010-11-24 | 2010-11-24 | Chinese medicine composition for treating fatty liver |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102058843B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293969A (en) * | 2011-09-09 | 2011-12-28 | 张�林 | Chinese medicine for treating fatty liver |
| CN102423442A (en) * | 2011-12-27 | 2012-04-25 | 峨眉山天梁星制药有限公司 | Double-component medicine for treating fatty liver and preparation method thereof |
| CN103070896A (en) * | 2013-01-10 | 2013-05-01 | 济南康众医药科技开发有限公司 | Medicine for curing liver-qi stagnation type tumourous fever |
| CN104815299A (en) * | 2015-06-01 | 2015-08-05 | 路云香 | Traditional Chinese medicine for treating fatty liver |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN101185747A (en) * | 2007-10-17 | 2008-05-28 | 门连社 | Prescription for treating hepatic disease |
-
2010
- 2010-11-24 CN CN2010105751494A patent/CN102058843B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
| CN101185747A (en) * | 2007-10-17 | 2008-05-28 | 门连社 | Prescription for treating hepatic disease |
Non-Patent Citations (2)
| Title |
|---|
| 《甘肃中医》 20080915 许海舰 脂肪肝的中医药治疗研究现状 第21卷, 第09期 2 * |
| 《辽宁中医药大学学报》 20080805 韦艾凌等 中医药治疗脂肪肝的研究进展 第10卷, 第08期 2 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102293969A (en) * | 2011-09-09 | 2011-12-28 | 张�林 | Chinese medicine for treating fatty liver |
| CN102293969B (en) * | 2011-09-09 | 2012-11-28 | 刘春青 | Chinese medicine for treating fatty liver |
| CN102423442A (en) * | 2011-12-27 | 2012-04-25 | 峨眉山天梁星制药有限公司 | Double-component medicine for treating fatty liver and preparation method thereof |
| CN102423442B (en) * | 2011-12-27 | 2014-06-18 | 峨眉山天梁星制药有限公司 | Double-component medicine for treating fatty liver and preparation method thereof |
| CN103070896A (en) * | 2013-01-10 | 2013-05-01 | 济南康众医药科技开发有限公司 | Medicine for curing liver-qi stagnation type tumourous fever |
| CN104815299A (en) * | 2015-06-01 | 2015-08-05 | 路云香 | Traditional Chinese medicine for treating fatty liver |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102058843B (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104474471A (en) | Traditional Chinese medicine composition for treating thyroid | |
| CN102058843B (en) | Chinese medicine composition for treating fatty liver | |
| CN104383088A (en) | Traditional Chinese medicine composition for treating postpartum abdominal pain | |
| CN105535390A (en) | Traditional Chinese medicine decoction for treating coronary heart disease and preparation method of traditional Chinese medicine decoction | |
| CN101700363B (en) | Traditional Chinese medicine for curing chronic atrophic gastritis | |
| CN103520669B (en) | The Chinese medicine for the treatment of phlegm-damp accumulation symptom pattern of syndrome obstruction of qi in the chest and cardialgia | |
| CN104984303A (en) | Traditional Chinese medicine composite for treating child jaundice | |
| CN104288745A (en) | Traditional Chinese medicine for treating CG (Chronic Gastritis) | |
| CN103230567A (en) | Traditional Chinese medicine particles for treating liver depression and phlegm coagulation nodules of breast | |
| CN105381424A (en) | Traditional Chinese medicine for detoxifying human viscera and preparation method of traditional Chinese medicine | |
| CN102068668A (en) | Chinese medicinal composition for treating hypochondriac pain | |
| CN104352955A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN104127815A (en) | Traditional Chinese medicinal honeyed pill for curing chronic coronary heart disease | |
| CN103479971A (en) | Chinese medicine preparation for curing hyperactivity of liver-yang | |
| CN103816366B (en) | A kind of medicine treating oral ulcer | |
| CN102688451B (en) | Chinese medicinal composition for treating alcoholic fatty liver | |
| CN105688035A (en) | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases | |
| CN101530556B (en) | Chinese traditional medicine preparation used for curing angina | |
| CN104225569A (en) | Chinese medicinal composition for treating chronic enteritis | |
| CN104306610A (en) | Traditional Chinese medicine for treating hyperacidity and preparation method of traditional Chinese medicine | |
| CN104398774A (en) | Traditional Chinese drug for treating diabetic peripheral neuropathy | |
| CN104225531A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN103372190B (en) | The medicine for the treatment of enteritis | |
| CN102462786A (en) | Sobering soup | |
| CN105311562A (en) | Traditional Chinese medicine for calming livers and reducing blood pressures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: WANG KELING Free format text: FORMER OWNER: RONGCHENG GANGYUAN DRAWNWORK PRODUCTS CO., LTD. Effective date: 20120110 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Keling Inventor after: Cong Xiuling Inventor after: Xia Yongping Inventor before: Xia Yongping |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 264300 WEIHAI, SHANDONG PROVINCE TO: 264200 WEIHAI, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: XIA YONGPING TO: WANG KELING CONG XIULING XIA YONGPING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120110 Address after: Weihai City Hospital No. 70 Heping Road in Huancui District of Weihai City, Shandong province 264200 Applicant after: Wang Keling Address before: 264300 No. 20 East Wenhua Road, Shandong, Rongcheng Applicant before: Rongcheng Gangyuan Drawnwork Products Co., Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20121124 |